Abstract:Abstract Background A critical component of disease progression in rheumatoid arthritis (RA) involves neovascularization associated with pannus formation. 2-methoxyestradiol (2ME2) is a naturally occurring molecule with no known physiologic function, although at pharmacologic concentrations it has antiproliferative and antiangiogenic activities. We investigated the impact of orally administered 2ME2 on the initiation and development of proliferative synovitis using the anti-collagen monoclonal antibodies (CAIA) model. Methods Severe polyarticular arthritis was induced in Balb/c female mice by administration of 2 mg of a monoclonal antibody cocktail intravenously into the tail vein of mice. Twenty-four hours following monoclonal antibody administration, mice were injected with 25 μg of LPS ( E. coli strain 0111:B4) via the intraperitoneal route. Treatment with 2ME2 (100, 75, 50, 25, 10, 1 mg/kg, p.o., daily), or vehicle control began 24 hrs following LPS challenge and continued to day 21. Hind limbs were harvested, sectioned and evaluated for DMARD activity and general histopathology by histomorphometric analysis and immunohistochemistry (vWF staining). In a separate study, different dosing regimens of 2ME2 (100 mg/kg; q.d. vs q.w. vs q.w. × 2) were evaluated. The effect of treatment with 2ME2 on gene expression of inflammatory cytokines and angiogenic growth factors in the joint space was evaluated 5 and 14 days after the induction of arthritis. Results Mice treated with 2ME2 beginning 24 hours post anti-collagen monoclonal antibody injection, showed a dose-dependent inhibition in mean arthritic scores. At study termination (day 21), blinded histomorphometric assessments of sectioned hind limbs demonstrated decreases in synovial inflammation, articular cartilage degradation, pannus formation, osteoclast activity and bone resorption. At the maximal efficacious dosing regimen (100 mg/kg/day), administration of 2ME2 resulted in total inhibition of the study parameters and prevented neovascularization into the joint. Examination of gene expression on dissected hind limbs from mice treated for 5 or 14 days with 2ME2 showed inhibition of inflammatory cytokine message for IL-1β, TNF-α, IL-6 and IL-17, as well as the angiogenic cytokines, VEGF and FGF-2. Conclusion These data demonstrate that in the CAIA mouse model of RA, 2ME2 has disease modifying activity that is at least partially attributable to the inhibition of neovascular development. Further, the data suggests new mechanistic points of intervention for 2ME2 in RA, specifically inhibition of inflammatory mediators and osteoclast activity.

Effectiveness of 2-Methoxyestradiol in Alleviating Angiogenesis Induced by Intracranial Venous Hypertension.

Endogenous Hormone 2‐methoxyestradiol Suppresses Venous Hypertension‐induced Angiogenesis Through Up‐ and Down‐regulating P53 and Id‐1

2-Methoxyestradiol Inhibits Intracerebral Hemorrhage- Induced Angiogenesis in Rats.

2-methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats

Multiple Effects of 2me2 and D609 on the Cortical Expression of Hif-1 Alpha and Apoptotic Genes in A Middle Cerebral Artery Occlusion-Induced Focal Ischemia Rat Model

Inhibiting HIF-1α by 2ME2 Ameliorates Early Brain Injury after Experimental Subarachnoid Hemorrhage in Rats

The Effect of Diltiazern on Patency Rate of Arteriovenous Anastomosis in Rat and How It Works

Disease modifying and antiangiogenic activity of 2-Methoxyestradiol in a murine model of rheumatoid arthritis

2-Methoxyestradiol Protects Against Lung Ischemia/Reperfusion Injury by Upregulating Annexin A1 Protein Expression

A Pivotal Role of the Vascular Endothelial Growth Factor Signaling Pathway in the Formation of Venous Hypertension-Induced Dural Arteriovenous Fistulas

Expression Of Hypoxia-Inducible Factor-1 And Vascular Endothelial Growth Factor In Response To Venous Hypertension

Estrogen Metabolite 2-Methoxyestradiol Prevents Hypertension in Deoxycorticosterone Acetate-salt Rats

2-Methoxyestradiol Attenuates Autophagy Activation after Global Ischemia

THE EFFECT OF HIF-1α INHIBITOR ON THE INJURY INDUCED BY FOCAL CEREBRAL ISCHEMIA AND REPERFUSION IN RATS

Suppression of Hypoxia-Inducible Factor-1Alpha and Its Downstream Genes Reduces Acute Hyperglycemia-Enhanced Hemorrhagic Transformation in a Rat Model of Cerebral Ischemia.

2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice

The Effect of Ecdysterone on Cerebral Vasospasm Following Experimental Subarachnoid Hemorrhage in Vitro and in Vivo

The Effects of Different Doses of Estradiol (E2) on Cerebral Ischemia in an in Vitro Model of Oxygen and Glucose Deprivation and Reperfusion and in a Rat Model of Middle Carotid Artery Occlusion.

Effects of Midazolam, Diazepam, Propofol and Dexmedetomidine on Endothelial Cell Proliferation and Angiogenesis Induced by Vegf

Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis

Effects of Docosahexaenoic Acid on Expression of Ang-2 and VEGF in Rat Brain Microvascular Endo-Thelial Cells Subjected to Oxygen-Glucose Deprivation